Form 4: Molina Healthcare Director Steven Orlando Reports Acquisition of Shares
SEC Form 4 Filing
Director Steven Orlando reports the acquisition of 189 shares of Molina Healthcare common stock on January 1, 2025, as part of the company's equity incentive plan.
Summary
- Steven Orlando, a director of Molina Healthcare, Inc., filed a Form 4 on January 2, 2025, reporting a transaction.
- On January 1, 2025, Mr. Orlando acquired 189 shares of Molina Healthcare common stock at a price of $291.05 per share.
- These shares were granted under the company's 2019 Equity Incentive Plan as part of his compensation for services as a director.
- The grant is part of a quarterly allocation of an annual equity award valued at $220,000, with $55,000 granted each quarter.
- Following the transaction, Mr. Orlando beneficially owns 18,375 shares held by the Orlando Family Trust and 1,500 shares held in his 401(k) plan.
- The filing also includes a Limited Power of Attorney, granting Jeff D. Barlow and Codruta Catanescu the authority to execute and file Forms 3, 4, and 5 on Mr. Orlando's behalf.
Sentiment
Score: 7
Explanation: The document reflects a standard transaction related to director compensation, indicating a stable and well-governed company. The sentiment is neutral to slightly positive.
Positives
- The equity grant aligns the director's interests with those of the shareholders.
- The consistent quarterly grants provide a steady stream of equity compensation.
Industry Context
This filing is a routine disclosure related to director compensation and is typical for publicly traded companies. It reflects standard practices for aligning director interests with shareholder value through equity-based compensation.
Comparison to Industry Standards
- Equity compensation for board members is a common practice across the healthcare industry.
- Companies like UnitedHealth Group (UNH) and Anthem (ANTM) also utilize equity incentive plans for their directors.
- The value of the equity grants is generally benchmarked against peer companies to ensure competitive compensation packages.
Stakeholder Impact
- The equity grant aligns the director's interests with those of the shareholders, potentially leading to better decision-making.
- The consistent equity compensation can help retain experienced directors.
Key Dates
| Date | Description |
|---|---|
| 2005-11-08 | Date of previous Limited Power of Attorney granted to Jeff D. Barlow and Mark L. Andrews. |
| 2011-02-16 | Date of the Limited Power of Attorney granted to Jeff D. Barlow and Codruta Catanescu. |
| 2024-12-31 | Closing price of Molina Healthcare common stock used to calculate the number of shares granted ($291.05). |
| 2025-01-01 | Date of the transaction (acquisition of shares). |
| 2025-01-02 | Date of the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.